REG - Peel Hunt Limited - Purchase of shares by Employee Benefit Trust

Peel HuntAnnouncement

04/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220304:nRSD6130Da&default-theme=true

RNS Number : 6130D  Peel Hunt Limited  04 March 2022

 4 March 2022

 

Peel Hunt Limited

("Peel Hunt" or the "Company")

 

 

Purchase of shares by Employee Benefit Trust

The Company and its group (the "Group") have an established Employee Benefit
Trust (the "EBT") in respect of the Group's share plans which is funded by the
Group and has the power to acquire ordinary shares from the Group or in the
open market to meet the Group's future obligations under these plans. The EBT
is a discretionary trust for the benefit of employees. The Company announces
that it has initially provided a recommendation (the "Recommendation") to the
independent trustee of the EBT, to acquire up to 1% of the issued share
capital of the Company over the next twelve months to satisfy share awards to
employees. Staff equity ownership and incentivisation have been key to the
success of the Group in the past and the directors believe will continue to be
crucial to future success. The Recommendation has been given in a manner which
will allow the EBT to make purchases through close periods. The Company will
either announce, or disclose in its Annual Report, any amendments or updates
to the Recommendation.

 

For further information, please contact:

 

 

 Peel Hunt via Engine MHP                     +44 (0)20 3128 8540

 Steven Fine, CEO

 Sunil Dhall, CFOO

 Engine MHP (Financial PR)                    +44 (0)20 3128 8540

                                              peelhunt@mhpc.com
 Andrew Jaques

 Charlie Barker

 Rachel Mann

 Robert Collett-Creedy

 Grant Thornton UK LLP (Nominated Adviser)    +44 (0)20 7728 2942

 Colin Aaronson

 Daphne Zhang

 

 

Notes to editors:

 

Peel Hunt is a leading specialist in UK Investment Banking, ranked number one
broker for UK mid and small-cap companies in Institutional Investor's latest
Europe Survey. Our purpose is to nurture and guide people through the
evolution of business.  We achieve this through a proven, joined-up approach
that consistently delivers value to UK corporates, global institutions and
trading counterparties alike.

 

We have 163 corporate clients (including 33 in the FTSE 100 and FTSE 250),
with an average market capitalisation of approximately £700m. Our
award-winning research is distributed to over 1,245 institutions across the
UK, Europe and US. Our trading platform makes markets in over 10,000
instruments in 38 markets and is an increasingly important provider of trade
execution services to the UK retail platforms and brokers.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSUOURRUWUORUR